Poster: AML-279 Molecularly-Defined De Novo and Secondary Acute Myeloid Leukemia Are Biologically and Clinically Different Entities

Emma Boertjes,Adil Al Hinai,Elodie Stoetman,Kyra G. Compagne,Tim Grob,Francois G. Kavelaars,Melissa Rijken,Mathijs Sanders,Berna H. Beverloo,Bob Löwenberg,Peter J.M. Valk

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览3

暂无评分

摘要

In conclusion, we revealed molecularly defined stAML as an AML subtype with a distinct genetic ontogeny that emphasizes a subgroup of patients with significantly worse clinical outcomes.

查看译文

关键词

AML,acute myeloid leukemia,genetics,neoplasm

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要